Rasburicase for the prevention and treatment of hyperuricemia in tumor lysis syndrome. [electronic resource]
- Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners Sep 2010
- 205-13 p. digital
Publication Type: Journal Article; Review
1477-092X
10.1177/1078155209348719 doi
Allopurinol--therapeutic use Antineoplastic Agents--adverse effects Gout Suppressants--therapeutic use Hematologic Neoplasms--drug therapy Humans Hyperuricemia--drug therapy Infusions, Intravenous Tumor Lysis Syndrome--drug therapy Urate Oxidase--therapeutic use